Latest AbbVie Stories
NORTH CHICAGO, Ill., Dec. 23, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Goldman Sachs Healthcare CEOs Unscripted Conference on Tuesday, Jan. 6, 2015. Richard A.
- AbbVie Presents for the First Time Results from the Venetoclax Phase 2 Program in Acute Myelogenous Leukemia NORTH CHICAGO, Ill., Dec.
- Major regulatory milestone achieved toward approval in the European Union NORTH CHICAGO, Ill., Nov.
Women take a stand to improve HIV care outcomes globally WASHINGTON, Nov.
Data from 13 accepted abstracts include: NORTH CHICAGO, Ill., Nov.
NORTH CHICAGO, Ill., Nov. 17, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Jefferies 2014 Global Healthcare Conference in London on Thursday, Nov. 20, 2014.
- Data include results from a Phase 1 study of ABT-414 as monotherapy and in combination with radiation and/or chemotherapy in patients with newly diagnosed and recurrent/unresectable glioblastoma
PARIS, November 12, 2014 /PRNewswire/ -- Collaboration to generate novel diagnostic products to support personalized therapies for
- In adult patients co-infected with genotype 1 (GT1) hepatitis C virus (HCV) infection and human immunodeficiency virus (HIV) type 1 infection, TURQUOISE-I demonstrated sustained virologic response
- Large; stout; burly.